Apollon Wealth Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56M Sell
138,227
-89,946
-39% -$1.2M 0.02% 571
2026
Q2
$3.33M Buy
+228,173
New +$3.02M 0.04% 369

Other funds holding CLBT

Apollon Wealth Management's CLBT Position: Q3 2026 in Review

Apollon Wealth Management reduced its Cellebrite (CLBT) stake by 39% in Q3 2026, selling an estimated $1.2M and leaving 138,227 shares worth $1.56M. The position accounts for 0.02% of the portfolio, ranked #571.

Apollon Wealth Management first reported a position in CLBT in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.33M in Q2 2026. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Apollon Wealth Management held 138,227 shares of Cellebrite worth $1.56M as of Q3 2026.
  • Apollon Wealth Management sold 89,946 Cellebrite shares in Q3 2026, an estimated $1.2M.
  • Cellebrite made up 0.02% of Apollon Wealth Management's portfolio in Q3 2026, its #571 holding.
  • Apollon Wealth Management first reported a position in Cellebrite in Q2 2026 and has held it in 2 quarters since.
  • Apollon Wealth Management's Cellebrite position peaked at $3.33M in Q2 2026.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.